FORMET 500 Metformin Hydrochloride 500mg Film-Coated Tablet 100's
We recognize that purchasing medications can be a deeply personal matter. To respect your privacy, we ensure that all orders are packaged discreetly, with no indication of the contents on the packaging. This means that even our couriers remain unaware of the package contents.
Furthermore, we uphold strict confidentiality standards. We guarantee that your order information will never be disclosed to any third party. Your trust is paramount to us, and we are committed to safeguarding your privacy at every step of the process. Our dedication to discretion and confidentiality is part of our unwavering commitment to you, our valued customer.
Features
- Metformin
Description
Indications/Uses
Dosage/Direction for Use
The dose should be increased gradually. One 500 mg tablet 3 times a day or two 850 mg tablets 2 times a day is often enough to give good diabetic control. This may be achieved within a few days, but it is not unusual for the full effect to be delayed for up to 2 weeks. If control is incomplete, a cautious increase in dosage to a maximum of 3 g daily is justified. Once control has been obtained, it may be possible to reduce the dosage. When combined with existing sulfonylurea therapy, which is not given adequate control, one 500 mg tablet should be added initially, the dosage of Metformin being gradually increased until optimal control is obtained. Often, the sulfonylurea may be reduced and in some patients, withdrawn. Metformin can then be continued as the sole therapy.
Overdosage
Treatment: Intensive supportive therapy is recommended which should be particularly directed at correcting fluid loss and metabolic disturbance.
Administration
Contraindications
Diabetic ketoacidosis should be treated with insulin.
Metformin should be temporarily discontinued in patients undergoing radiologic studies involving intravascular administration of iodinated contrast materials, because use of such products may result in acute alteration of renal function.
Warnings
Special Precautions
Adverse Reactions
Hypoglycaemia is rare with a biguanide given alone, although it may occur if other contributing factors or drugs are present.
Lactic acidosis, sometimes fatal, has occurred with biguanides, primarily with phenformin. When it has occurred with metformin most cases have been in patients whose condition contraindicated the use of the drug, particularly those with renal impairment.
Drug Interactions
In general fewer drug interactions have been reported with biguanides than with sulfonylureas. Alcohol may increase the risk of lactic acidosis as well as of hypoglycaemia. Care should be taken if biguanides given with drugs that may impair renal function.